Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLS-ILB-E710c in CIN3
NCT02195089Phase 2Completed
- Sponsor
- MOA Life Plus Co. Ltd.
- Start
- Mar 2014
- Primary completion
- Mar 2016
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BLS-M07 in cervical intraepithelial neoplasia (CIN), sponsored by MOA Life Plus Co. Ltd.. Started Mar 2014; status: completed.
02
Drugs
BLS-M07
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT02195089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195089.